Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meetingBoris Jülg, Bruce D. Walker, Lynda Dee et al.|The Lancet HIV|2019Cited by 206
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections ForumPer Ljungman, Dana G. Wolf, Martha Fournier et al.|Clinical Infectious Diseases|2024Cited by 145
HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Mitchell Leus, Thomas R. Battersby et al.|Hepatology|2023Cited by 48
Perceptions of Equipoise, Risk–Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative InquiryKarine Dubé, Stuart Rennie, Lynda Dee et al.|Journal of Empirical Research on Human Research Ethics|2017Cited by 40